Form D · Agriculture
Hanimune Therapeutics Inc
Philadelphia, PA · CIK 0001769072
Offering snapshot reported Feb 7, 2023 · SEC filing
- Reported sold
- $3.3M Offering amount: $5.06M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2023 | Initial | $3,304,288 | No comparison | 33 | SEC filing |
| Mar 10, 2021 | Initial | $759,360 | No comparison | 16 | SEC filing |
| Nov 25, 2019 | Initial | $0 | No comparison | 1 | SEC filing |
| Nov 22, 2019 | Amendment | $680,000 | $100,000vs Apr 26, 2019 | 14 | SEC filing |
| Apr 26, 2019 | Amendment | $580,000 | $50,000vs Feb 26, 2019 | 13 | SEC filing |
| Feb 26, 2019 | Initial | $530,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-472872
$1,772,907.95 of the Total Offering Amount and Total Amount Sold includes principal and interest due on certain instruments convertible or exercisable into equity of the Issuer.
Source: Form D, filed Feb 7, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Meenal Lele | Director, Executive |
| Hany Michail | Director |
Issuer details
Industry: Agriculture (See others in industry)
Address:
1711 North Howard Street
Philadelphia, PA, 19122
Philadelphia, PA, 19122